Multi-omic analysis reveals prognostic and immune characteristics of cuproptosis for lung adenocarcinoma

Author:

Xie Fuquan1,Su Yongcheng2,Xie Lei3,Shen Qianwen2,Lei Ziyu2,Li Jiangquan2,Zhang Wenqing2,Xu Beibei4,Hu Tianhui2

Affiliation:

1. Chinese Academy of Sciences Shenzhen Institutes of Advanced Technology - Shenzhen, Guangdong, CN

2. Xiamen University

3. The First Affiliated Hospital of Shantou University Medical College

4. Chinese Academy of Sciences

Abstract

Abstract Background: Cuproptosis is a newly defined form of regulated cell death triggered by excess copper and is distinct from other known types of cell death. Currently, reliable prognostic signatures based on cuproptosis-related regulators are underdeveloped. Herein, we aimed to investigate the cuproptosis landscape in lung adenocarcinoma (LUAD). Materials and Methods:We downloaded gene expression data and corresponding clinical information from The Cancer Genome Atlas and Gene Expression Omnibus. Cuproptosis subtypes were identified using unsupervised clustering based on the expression of 10 cuproptosis-related regulatory genes, including seven positively (FDX1, LIAS, LIPT1, DLAT, DLD, PDHA1, and PDHB) and three negatively (CDKN2A, GLS, and MTF1) correlated genes. CDKN2A expression was detected using immunohistochemistry tissue microarrays. Results: Unsupervised clustering revealed two LUAD cuproptosis-related subtypes (A and B). Patients with subtype B had a higher survival rate and were significantly enriched in innate immune cells compared to those with subtype A. We built a cuproptosis-related risk model (CRM) to calculate a risk score for each patient; the score was positively correlated with patient prognosis. Somatic mutation landscape analysis revealed a significant negative relationship between tumor mutational burden (TMB) and the CRM score. Patients with both a low CRM score and TMB had the worst prognosis. Immune landscape analysis revealed that patients with a high CRM score had a higher tumor immune dysfunction and exclusion score, suggesting a poorer immunotherapy response rate. Conclusion: Single-cell CRM score quantification revealed its correlation with the enrichment of different immune cell types in LUAD.

Publisher

Research Square Platform LLC

Reference95 articles.

1. B. C. Bade, and C. S. Dela Cruz, "Lung Cancer 2020: Epidemiology, Etiology, and Prevention," CLINICS IN CHEST MEDICINE, vol. 41, no. 1, pp. 1–24, 2020.

2. "Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies,";Jordan EJ;Cancer Discovery,2017

3. Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma;Zhang Y;CANCER SCIENCE,2020

4. Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion,";Greenawalt EJ;MOLECULAR CANCER RESEARCH,2019

5. Personalized therapy for lung cancer: striking a moving target,";Pakkala S;JCI Insight,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3